A major advance in cancer research is emerging with the use of nanobodies to re-engage dysfunctional p53. This crucial malignant inhibitor protein is frequently inactivated in various forms of malignancies, resulting https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research